Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Pharmacogenet Genomics. 2009 Mar;19(3):206–216. doi: 10.1097/FPC.0b013e328323f680

Table 4.

Resistance factors of transfected HEK293 cells to chemotherapeutic agents.

Resistance factorsa
Drugs WT-MRP1/ABCC1 Cys43Ser (128G>C) Thr73lle (218C>T) Arg723Gln (2168G>A) Arg1058Gln (3173G>A)
Cisplatin 0.95±0.24 0.95±0.14 0.83±0.18 0.76±0.20 1.10±0.10
Paclitaxel 1.14±0.09 0.99±0.16 0.99±0.21 1.10±0.22 1.04±0.16
Daunorubicin 17.82±3.15 17.27±2.37 19.73±1.98 9.09±1.68 8.73±2.62
Doxorubicin 14.38±0.75 15.13±0.91 14.63±1.52 3.63±1.20 2.38±1.03
Etoposide 12.65±2.09 11.51±1.92 13.08±1.84 4.41±0.67 6.65±1.05
Methotrexate 10.80±1.33 10.50±1.58 6.70±0.95 6.20±0.90 10.70±1.26
Vinblastine 5.44±1.36 5.72±1.60 5.64±1.04 2.80±1.26 5.44±1.62
Vincristine 11.35±3.11 11.17±2.91 8.89±2.40 3.76±1.15 11.18±2.82
a

Resistance factors=IC50 of wild-type or mutant MRP1/ABCC1 transfected cells/IC50 of empty vector control transfected cells.